Quality assessment in endoscopy "artificial intelligence in endoscopy" [0.03%]
内镜人工智能在质量控制中的作用——人工智在内镜的应用研讨会纪要
Yuchi Mori,Masashi Misawa
Yuchi Mori
Quality of care during endoscopy is greatly influenced by endoscopists' competence and efforts, which is unfortunately subject to variability. The recent transformative role of artificial intelligence (AI) is expected to improve endoscopy q...
Franco Ana Rita,Arvanitakis Marianna,Teles de Campos Sara
Franco Ana Rita
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a technically complex and high-risk procedure for managing pancreaticobiliary diseases. The quality assessment in ERCP has evolved from relying solely on adverse events (AEs) rates to...
Preface to special edition: Screening and Early diagnosis of upper gastrointestinal neoplastic lesions [0.03%]
本期导读：上消化道肿瘤的筛查和早诊早治
J Honing,M Dinis-Ribeiro
J Honing
Novel devices and biomarkers in screening for esophageal squamous cell cancer [0.03%]
新型的筛查装置和生物标志物在食管鳞癌中的应用研究进展
Wladyslaw Januszewicz,Karol Nowicki-Osuch
Wladyslaw Januszewicz
Esophageal squamous cell carcinoma (ESCC) remains a significant global health challenge, with high mortality rates primarily due to late-stage diagnosis. Detecting ESCC at an early stage, when still amenable to endoscopic resection, could p...
Artificial intelligence in early screening for esophageal squamous cell carcinoma [0.03%]
人工智能在食管鳞癌早期筛查中的应用研究进展
Si-Yan Yan,Xin-Yu Fu,Yan Yang et al.
Si-Yan Yan et al.
Esophageal squamous cell carcinoma (ESCC) remains a significant global health burden with high incidence and mortality rates, particularly in developing regions. Early detection is crucial for improving patient survival, yet conventional sc...
Post-endoscopy upper gastrointestinal cancer: Emerging data and opportunities to improve early detection [0.03%]
内镜检查后上消化道癌症：新的数据和改善早期检测的机会
Mie Thu Ko,Adriel Fung,Anjana Kumar et al.
Mie Thu Ko et al.
The overall prognosis of upper gastrointestinal cancer remains very poor. Early diagnosis is key to avoid morbidity and improve long-term survival. While gastroscopy is the gold standard diagnostic test, premalignant or malignant abnormalit...
Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives [0.03%]
巴雷特食管筛查：当前模式、基于风险的方法和未来展望
Nanda Provoost,Rebecca C Fitzgerald,Judith Honing
Nanda Provoost
Barrett's Esophagus (BE) is a precursor lesion of esophageal adenocarcinoma (EAC). To enable early detection of neoplasia, BE patients undergo regular endoscopic surveillance. However, more than 90 % of EAC patients were not previously diag...
Annemijn D I Maan,Laurèlle van Tilburg,Arjun D Koch
Annemijn D I Maan
The incidence of oesophageal squamous cell carcinoma accounts for almost 85 % of all oesophageal cancers worldwide. Patients with oesophageal cancer can present with clinical symptoms including dysphagia, weight loss, retrosternal discomfor...
Catarina Lopes,Carina Pereira
Catarina Lopes
Gastric cancer is a pressing global health issue that ranks fifth as the most commonly diagnosed malignancy and leading cause of cancer-related deaths. Early detection is critical for improving patient outcomes, with five-year survival rate...
Cost-effectiveness of upper endoscopy for gastric cancer screening and surveillance in Western populations [0.03%]
西方人群胃癌筛查和随访内镜检查的成本效益分析
N E A Kapteijn,D T Mülder,I Lansdorp-Vogelaar
N E A Kapteijn
Background: Gastric cancer (GC) is the fourth leading cause of cancer-related deaths worldwide, with highest incidence rates in Asia. Endoscopic screening may facilitate early detection and reduces mortality, but its cost...